Evering TH, Chew KW, Giganti MJ, Moser C, et al. Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19. Ann Intern Med 2023 Apr 18. doi: 10.7326/M22-3428.
PMID: 37068272